Size | Price | Stock | Qty |
---|---|---|---|
1g |
|
||
2g |
|
||
5g |
|
||
10g |
|
||
Other Sizes |
|
Purity: ≥98%
Hydrocortisone (Cortisol; H-Cort) is a steroid hormone and/or endogenous glucocorticoid produced by the adrenal gland for the treatment of adrenocortical insufficiency. Hydrocortisone is a corticosteroid with anti-inflammatory and immunosuppressive properties. Hydrocortisone initially binds to the cytoplasmic glucocorticoid receptor then the receptor-ligand complex is translocated to the nucleus where it initiates the transcription of genes encoding for anti-inflammatory mediators, such as cytokines and lipocortins.
ln Vitro |
Hydrocortisone (50 nM) reveals dose-dependent downregulation of GR transcripts in hCMEC/D3 cells. Supplementation of Hydrocortisone in serum-reduced cell differentiation media resulted in a considerable increase in TER in hCMEC/D3 monolayers [1]. Hydrocortisone-treated dendritic cells (DC) revealed lower expression of MHC II molecules, the costimulatory molecule CD86, and the DC-specific marker CD83, as well as a substantial reduction in IL-12 release. Hydrocortisone-treated DC decreased IFN-γ production but produced enhanced IL-4 release without changes in IL-5 [2]. Hydrocortisone lowers postischemic oxidative stress, perfusion pressure, and exudate production. Hydrocortisone suppresses post-ischemic shedding of syndecan-1, heparan sulfate and hyaluronan, and histamine release from resident mast cells [3].
|
||
---|---|---|---|
ln Vivo |
|
||
Animal Protocol |
|
||
References |
[1]. Förster C, et al. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol. 2008 Apr 1;586(7):1937-49.
[2]. Bellinghausen I, et al. Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol. 2001 Aug;108(2):242-9. [3]. Chappell D, et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology. 2007 Nov;107(5):776-8 |
Molecular Formula |
C21H30O5
|
|
---|---|---|
Molecular Weight |
362.46
|
|
CAS # |
50-23-7
|
|
Related CAS # |
Hydrocortisone 17-butyrate;13609-67-1;Hydrocortisone acetate;50-03-3;Hydrocortisone 17-valerate;57524-89-7;Hydrocortisone hemisuccinate;2203-97-6;Hydrocortisone-d7;Hydrocortisone-d4;73565-87-4;Hydrocortisone-d3;115699-92-8;Hydrocortisone phosphate;3863-59-0;Hydrocortisone (Standard);50-23-7;Hydrocortisone-d2;1257650-73-9
|
|
SMILES |
O([H])[C@]1(C(C([H])([H])O[H])=O)C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])[C@]([H])(C([H])([H])[C@@]21C([H])([H])[H])O[H])=O
|
|
InChi Key |
JYGXADMDTFJGBT-VWUMJDOOSA-N
|
|
InChi Code |
InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1
|
|
Chemical Name |
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
|
|
Synonyms |
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
|
---|
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.7589 mL | 13.7946 mL | 27.5893 mL | |
5 mM | 0.5518 mL | 2.7589 mL | 5.5179 mL | |
10 mM | 0.2759 mL | 1.3795 mL | 2.7589 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.